NCT05387109 2022-05-24
pcwaintrl
Tang-Du Hospital
Phase 4 Unknown
Clinical Trials
3 trialsNCT04164745 2019-11-15
Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung Cancer
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03799601 2019-01-10
ALTER-L013
Tongji Hospital
Phase 4 Unknown